INTRODUCTION

VOGTID MD 0.2 TABLET contains Voglibose which belongs to the group of medicines called Anti-diabetics. It is used in the treatment of type 2 diabetes mellitus along with diet and exercise to improve post-prandial blood glucose levels (when only diet and/or exercise or oral hypoglycemic drugs or insulin preparation in addition to diet and/or exercise does not result in adequate glycemic control).

Type 2 diabetes is a chronic medical condition in which the body does not make enough insulin, or the produced insulin does not work well. Symptoms include excessive urination, excessive thirst, hunger, fatigue, and blurred vision.    

Along treatment with VOGTID MD 0.2 TABLET follow regular exercise and diet plan as advised by your doctor to achieve better results. 

VOGTID MD 0.2 TABLET is not recommended for use in patients having severe ketosis, in a state of diabetic coma or pre-coma, severe infection, before and after an operation or with serious trauma and gastrointestinal obstruction.

VOGTID MD 0.2 TABLET should be used with caution in patients undergoing abdominal laparotomy for gallstone ileus or have roemheld’s syndrome, stenosis, liver, and kidney problems, and in elderly patients.

VOGTID MD 0.2 TABLET is not recommended for use among pregnant, breastfeeding women, children, and adolescents.

The most common side effects of taking VOGTID MD 0.2 TABLET are soft stools or diarrhea, flatulence, bloating, abdominal pain or discomfort, abdominal fullness, and nausea. Contact your doctor if any of the above symptoms worsen.

USES OF VOGTID MD 0.2 TABLET

• Treats type 2 diabetes mellitus along with diet and exercise

HOW VOGTID MD 0.2 TABLET WORKS

VOGTID MD 0.2 TABLET works by inhibiting the intestinal enzymes that are responsible for breaking complex sugars into simple sugars such as glucose. This prevents the level of blood glucose from increasing very high immediately after meals.

DIRECTIONS FOR USE

Take VOGTID MD 0.2 TABLET as advised by your physician. Your physician will decide the correct dose and duration for you depending upon your age, body weight and disease condition.

SIDE EFFECTS OF VOGTID MD 0.2 TABLET

HOW TO MANAGE SIDE EFFECTS

Nausea:

Take this medicine with, or just after meals. Stick to simple meals. Avoid eating oil-rich or spicy foods. In case of no improvement, consult your doctor.

Flatulence:

Eat smaller and frequent meals. Slowly eat and drink, and exercise regularly. If the symptom does not improve, contact your physician.

Diarrhea:

Drink more fluids, such as water or fruit juice to keep yourself hydrated. Do not take any medicine on your own without consulting your physician.

Stomach pain:

Try to rest and relax. Eat and drink slowly or try to have smaller and frequent meals. Keep a heating pad on your stomach. If the symptom does not improve, contact your physician.

WARNING & PRECAUTIONS

INTERACTIONS

A. Drug-Drug interactions:

Before taking VOGTID MD 0.2 TABLET, inform your physician if you are taking any of the following medicines:

• other antidiabetic drugs (Ex. glipizide, tolbutamide, insulin) (used to treat diabetes)
• medicines used to treat heart problems (Ex. metoprolol, atenolol)
• medicine used to treat skin infection (Ex. salicylic acid)
• medicines used to treat depression (Ex. phenelzine, selegiline)
• medicine used to treat cholesterol (Ex. fenofibrate)
• epinephrine (medicine used to treat anaphylaxis reactions)
• adrenocorticotrophin (medicine used to treat disorders of the pituitary or adrenal glands like Cushing’s syndrome)
• thyroxine (medicine used to treat thyroid problems)

Overdosage:

If you or anyone else accidentally take too much of VOGTID MD 0.2 TABLET, consult your physician immediately or visit the nearby hospital. The symptoms of overdosage are low blood sugar levels, abdominal discomfort and diarrhea.

SYNOPSIS

MORE INFORMATION

• Keep VOGTID MD 0.2 TABLET out of reach of children
• Store at a room temperature

FAQs ABOUT VOGTID MD 0.2 TABLET

Can VOGTID MD 0.2 TABLET cause diarrhea?

Diarrhea is the common side-effect of VOGTID MD 0.2 TABLET. Drink more fluids, such as water or fruit juice to keep yourself hydrated. Do not take any medicine on your own to treat diarrhea without consulting your physician.

Who should not take VOGTID MD 0.2 TABLET?

VOGTID MD 0.2 TABLET is not recommended for use in patients having severe ketosis, in a state of diabetic coma or pre-coma, severe infection, before and after an operation, or with serious trauma and gastrointestinal obstruction.

What if I forget to take a dose of VOGTID MD 0.2 TABLET?

You should take VOGTID MD 0.2 TABLET immediately when you remember. If it is time for your next dose skip missed the dose and follow your regular dose schedule. Do not double the dose to match up your missed dose. 

How to take VOGTID MD 0.2 TABLET?

Take VOGTID MD 0.2 TABLET as advised by your physician. Your physician will decide the correct dose and duration for you depending upon your age, body weight, and disease condition.

What are the common side effects of VOGTID MD 0.2 TABLET?

The most common side effects of taking VOGTID MD 0.2 TABLET are soft stools or diarrhea, flatulence, bloating, abdominal pain or discomfort, abdominal fullness, and nausea. Contact your physician if any of the symptoms worsen.

What happens when I take an overdose of VOGTID MD 0.2 TABLET?

If you or anyone else accidentally take too much of VOGTID MD 0.2 TABLET, consult your physician immediately or visit the nearby hospital. The symptoms of overdosage are low blood sugar levels, abdominal discomfort and diarrhea.

REFERENCES

1. Alvin C. Powers and David D’Alessio. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia. Goodman & Gilman’s: The Pharmacological basics of Therapeutics. 13th Edition. New York McGraw Hill Medical 2018. Page – 863-886.

2. KD. Tripathi. Insulin, Oral Hypoglycemic Drugs and Glucagon. Essentials of medical pharmacology. Seventh edition. 2013. Page – 258-281.

3. Ajay S. Dabhi, Nikita R. Bhatt, and Mohit J. Shah. Voglibose: An Alpha Glucosidase Inhibitor. Journal of Clinical and Diagnostic Research. December 2013 [Accessed on 21st June 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919386/

4. Sanjay Kalra, A Panneer Selvam, Amish V Shah, Kudugunti Neelaveni, Navneet Agrawal, Sambit Das, Vinay K Dhandhania, Subodh Jain, Pankaj Kumar Jha and Neha Rava. Prospective Multicenter Observational Study of Voglibose in Type 2 Diabetes-Victory. Journal of US Endocrinology. January 2020 [Accessed on 21st June 2022] https://www.researchgate.net/publication/342024938_Prospective_Multicenter_Observational_Study_of_Voglibose_in_Type_2_Diabetes-VICTORY

5. Cipla Ltd. Prandal MD Tablets (Voglibose). Cilpamed. [Revised in August 2015] [Accessed on 21st June 2022] https://www.ciplamed.com/content/prandial-md-tablets

6. Amigoz life sciences. Voglibose Tablets. [Accessed on 21st June 2022] http://amigozlife.com/voglibose-tablets.html

7. DM Pharma. Voglibose Tablet. Antidiabetic agents. [Accessed on 21st June 2022] http://www.dmpharma.co.in/Voglibose.html

USEFUL DIAGNOSTIC TESTS

• Glucose - Fasting Blood
• Glucose - Postprandial Blood
• Glycosylated Hemoglobin